CClinicalTrials.gg
CompletedNCT05662566Updated Apr 6, 2025

Risk of Failed Epidural in Patients With and Without Chronic Pain and Opioid Use

An observational study in Chronic Pain, Postoperative Pain and Central Sensitisation, sponsored by Eske Kvanner Aasvang. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-06.

Sponsored by Eske Kvanner Aasvang · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

Patients with chronic pain syndrome (CPS) may develop central sensitization wich may lead to increased pain intensity and lower pain threshold sometimes to the extend of hyperalgesia and allodynia. Furthermore, patients with daily use of opioids may develop opioid tolerance, and to a lesser extent opioid induced hyperalgesia.

These factors may lead to a higher pain intensity in the perioperative setting resulting in the observed increased opioid dosage needed to treat the acute pain. Furthermore opioid titration may be difficult with higher levels of pain and a higher risk of opioid related adverse effects incl. respiratory depression and sedation.

The factors above advocate for utilizing opioid sparing analgesic techniques. In our department as in many others we use an multimodal opioid sparing approach for surgical procedures including epidural anesthesia (EA) as a standard part of the perioperative analgesia strategy after upper laparotomy, as a sufficient epidural anesthesia has shown to provide a stable and often better pain relief than systemic opioids in these patients.

Clinically, there is a suspicion that patients with CPS on fixed opioid treatment have a higher frequency of need for epidural optimization, despite the lack of an anatomical reason for this. One potential explanation could be an altered nociception, requesting another EA strategy than in non-opioid patients.

Purpose and hypothesis This study will explore the frequency of failed EA, defined as EA with insufficient analgesic effect to the extent were replacements of the epidural is needed within the first 5 postoperative days (PODs), testing the hypothesis that failed epidural occurs more frequent in patients with CPS on fixed opioid treatment than in non-opioid patients without CPS.

02

Conditions studied

  • Chronic Pain
  • Postoperative Pain
  • Central Sensitisation

Browse trials for

Keywords

  • Failed epidural
  • Chronic pain syndrome
  • Central Sensitization
  • Opioid use
  • Opioid Naive
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients with or without chronic pain and opioid use undergoing elective laparotomi with epidural anesthesia as a part of the postoperative pain treatment.

Inclusion criteria

  • Patients undergoing elective laparotomy with epidural anesthesia as a part of the postoperative pain treatment
  • For the intervention group - Patients with chronic pain disorder defined as pain for more than 3 months and a daily use of opioids regardless of dosage.
  • For the control group - No chronic pain disorder defined as no daily use of opioid or other medicine with strong analgetic effect. A daily use of Acetaminophen and NSAIDs were deemed acceptable.

Exclusion criteria

Exclusion Criteria:

  • Patients with substance abuse
  • Suspected withdrawal due to opioid deficiency - noted in the medical chart
04

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
150 participants (actual)
Patient registry
No

Groups and cohorts

  • Chronic pain

    Patients with chronic pain and fixed opioid use, undergoing laparotomy with epidural anesthesia as a part of the postoperative analgesic strategy

    Procedure: Epidural replacement

  • No chronic pain

    Patients without chronic pain and without fixed opioid use, undergoing laparotomy with epidural anesthesia as a part of the postoperative analgesic strategy

    Procedure: Epidural replacement

Interventions

  • ProcedureEpidural replacement

    Insufficient analgesic effect of epidural anesthesia to the extent were replacement of the catheter is needed. Defined as insertion of a new epidural catheter

05

What researchers measure

Primary outcomes

  1. Epidural replacement

    Number of patients with the need of a new insertion of the epidural catheter

    Time frame: 5 days postoperative

Secondary outcomes

  1. Length of stay at the - post anaesthetic care unit (PACU) / Ward / Hospital

    Length of stay at post anaesthetic care unit / the surgical ward / entire admission. Defined from admission until discharged from the specific unit.

    Time frame: Total time of hospital stay up to 52 weeks

  2. postoperative epidural optmisation

    Return to the post anaesthetic care unit for epidural optimisation with medicine titration or retraction of the epidural catheter

    Time frame: 5 days postoperative

  3. Number of epidural replacements

    Number of epidural replacements per patient

    Time frame: 5 days postoperative

06

Study locations

1 site
  • Eske Kvanner Aasvang [eaasvang]
    Copenhagen, Denmark
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05662566
Lead sponsor
Eske Kvanner Aasvang
Responsible party
Eske Kvanner Aasvang (Professor, MD, DMSci, Rigshospitalet, Denmark) — Sponsor-investigator
First posted
Dec 22, 2022
Start date
Mar 17, 2023
Primary completion
Apr 2, 2025
Completion
Apr 2, 2025
Last update
Apr 6, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion